Search research articles
Contact Us
Filters
Showing results (481-490 of 636) with videos related to
Page
of 64
Sort By:
International Journal of Molecular Sciences
|
December 30, 2020
<i>Wisteria floribunda</i> Agglutinin-Positive Mac-2 Binding Protein as a Screening Tool for Significant Liver Fibrosis in Health Checkup
Nobuharu Tamaki, Masayuki Kurosaki, Yuka Takahashi, et al.
Hepatology (Baltimore, Md.)
|
April 24, 2019
MRI Assessment of Treatment Response in HIV-associated NAFLD: A Randomized Trial of a Stearoyl-Coenzyme-A-Desaturase-1 Inhibitor (ARRIVE Trial)
Veeral H Ajmera, Edward Cachay, Christian Ramers, et al.
Research Square
|
January 30, 2023
The Nimble Stage 1 Study Validates Diagnostic Circulating Biomarkers for Nonalcoholic Steatohepatitis
Arun Sanyal, Sudha Shankar, Katherine Yates, et al.
Cell Metabolism
|
March 30, 2022
Early prediction of incident liver disease using conventional risk factors and gut-microbiome-augmented gradient boosting
Yang Liu, Guillaume Méric, Aki S Havulinna, et al.
Alimentary Pharmacology & Therapeutics
|
February 14, 2025
Clinical Trial to Assess the Safety and Tolerability of Anti-IL 23 Monoclonal Antibody Guselkumab in Patients With Alcohol-Associated Liver Disease
Luis Antonio Diaz, Sheldon Morris, Shravan Dave, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 22, 2024
Lipid-associated macrophages' promotion of fibrosis resolution during MASH regression requires TREM2
Souradipta Ganguly, Sara Brin Rosenthal, Kei Ishizuka, et al.
The New England Journal of Medicine
|
October 20, 2021
Prospective Study of Outcomes in Adults with Nonalcoholic Fatty Liver Disease
Arun J Sanyal, Mark L Van Natta, Jeanne Clark, et al.
Hepatology (Baltimore, Md.)
|
April 17, 2020
Clinical Best Practice Advice for Hepatology and Liver Transplant Providers During the COVID-19 Pandemic: AASLD Expert Panel Consensus Statement
Oren K Fix, Bilal Hameed, Robert J Fontana, et al.
Hepatology Communications
|
July 19, 2021
Improvements of Fibrosis and Disease Activity Are Associated With Improvement of Patient-Reported Outcomes in Patients With Advanced Fibrosis Due to Nonalcoholic Steatohepatitis
Zobair M Younossi, Maria Stepanova, Mazen Noureddin, et al.
Hepatology (Baltimore, Md.)
|
June 18, 2016
Shared genetic effects between hepatic steatosis and fibrosis: A prospective twin study
Jeffrey Cui, Chi-Hua Chen, Min-Tzu Lo, et al.
Page
of 64
Search research articles
Search
Showing results (481-490 of 636) with videos related to
Sort By:
Page
of 64
International Journal of Molecular Sciences
|
December 30, 2020
<i>Wisteria floribunda</i> Agglutinin-Positive Mac-2 Binding Protein as a Screening Tool for Significant Liver Fibrosis in Health Checkup
Nobuharu Tamaki, Masayuki Kurosaki, Yuka Takahashi, et al.
Hepatology (Baltimore, Md.)
|
April 24, 2019
MRI Assessment of Treatment Response in HIV-associated NAFLD: A Randomized Trial of a Stearoyl-Coenzyme-A-Desaturase-1 Inhibitor (ARRIVE Trial)
Veeral H Ajmera, Edward Cachay, Christian Ramers, et al.
Research Square
|
January 30, 2023
The Nimble Stage 1 Study Validates Diagnostic Circulating Biomarkers for Nonalcoholic Steatohepatitis
Arun Sanyal, Sudha Shankar, Katherine Yates, et al.
Cell Metabolism
|
March 30, 2022
Early prediction of incident liver disease using conventional risk factors and gut-microbiome-augmented gradient boosting
Yang Liu, Guillaume Méric, Aki S Havulinna, et al.
Alimentary Pharmacology & Therapeutics
|
February 14, 2025
Clinical Trial to Assess the Safety and Tolerability of Anti-IL 23 Monoclonal Antibody Guselkumab in Patients With Alcohol-Associated Liver Disease
Luis Antonio Diaz, Sheldon Morris, Shravan Dave, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 22, 2024
Lipid-associated macrophages' promotion of fibrosis resolution during MASH regression requires TREM2
Souradipta Ganguly, Sara Brin Rosenthal, Kei Ishizuka, et al.
The New England Journal of Medicine
|
October 20, 2021
Prospective Study of Outcomes in Adults with Nonalcoholic Fatty Liver Disease
Arun J Sanyal, Mark L Van Natta, Jeanne Clark, et al.
Hepatology (Baltimore, Md.)
|
April 17, 2020
Clinical Best Practice Advice for Hepatology and Liver Transplant Providers During the COVID-19 Pandemic: AASLD Expert Panel Consensus Statement
Oren K Fix, Bilal Hameed, Robert J Fontana, et al.
Hepatology Communications
|
July 19, 2021
Improvements of Fibrosis and Disease Activity Are Associated With Improvement of Patient-Reported Outcomes in Patients With Advanced Fibrosis Due to Nonalcoholic Steatohepatitis
Zobair M Younossi, Maria Stepanova, Mazen Noureddin, et al.
Hepatology (Baltimore, Md.)
|
June 18, 2016
Shared genetic effects between hepatic steatosis and fibrosis: A prospective twin study
Jeffrey Cui, Chi-Hua Chen, Min-Tzu Lo, et al.
Page
of 64